These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome. Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096 [TBL] [Abstract][Full Text] [Related]
3. Expression of p21WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma. Natsugoe S; Nakashima S; Matsumoto M; Xiangming C; Okumura H; Kijima F; Ishigami S; Takebayashi Y; Baba M; Takao S; Aikou T Clin Cancer Res; 1999 Sep; 5(9):2445-9. PubMed ID: 10499617 [TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients. Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348 [TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of cell cycle regulators in gastric carcinoma]. Wu JF; Shao JC; Wang DB; Qin R; Zhang H Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028 [TBL] [Abstract][Full Text] [Related]
6. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma. Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y Acta Otolaryngol; 2005 Jul; 125(7):779-85. PubMed ID: 16012042 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Kato K; Hida Y; Miyamoto M; Hashida H; Shinohara T; Itoh T; Okushiba S; Kondo S; Katoh H Cancer; 2002 Feb; 94(4):929-33. PubMed ID: 11920460 [TBL] [Abstract][Full Text] [Related]
8. Expression of p53 and p21 is useful for the prediction of preoperative chemotherapeutic effects in esophageal carcinoma. Nakashima S; Natsugoe S; Matsumoto M; Kijima F; Takebayashi Y; Okumura H; Shimada M; Nakano S; Kusano C; Baba M; Takao S; Aikou T Anticancer Res; 2000; 20(3B):1933-7. PubMed ID: 10928129 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375 [TBL] [Abstract][Full Text] [Related]
10. Mutated p53 protein expression and proliferative activity in advanced gastric cancer. Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058 [TBL] [Abstract][Full Text] [Related]
11. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value. Kapranos N; Stathopoulos GP; Manolopoulos L; Kokka E; Papadimitriou C; Bibas A; Yiotakis J; Adamopoulos G Anticancer Res; 2001; 21(1B):521-8. PubMed ID: 11299798 [TBL] [Abstract][Full Text] [Related]
12. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach. Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266 [TBL] [Abstract][Full Text] [Related]
13. Mutant p53 in patients with invasive cervical cancer stages IB to IIB. Kainz C; Kohlberger P; Gitsch G; Sliutz G; Breitenecker G; Reinthaller A Gynecol Oncol; 1995 May; 57(2):212-4. PubMed ID: 7729736 [TBL] [Abstract][Full Text] [Related]
14. Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma. Okumura H; Natsugoe S; Yokomakura N; Kita Y; Matsumoto M; Uchikado Y; Setoyama T; Owaki T; Ishigami S; Aikou T Clin Cancer Res; 2006 Jun; 12(12):3740-5. PubMed ID: 16778101 [TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers. Kato H; Yoshikawa M; Fukai Y; Tajima K; Masuda N; Tsukada K; Kuwano H; Nakajima T Anticancer Res; 2000; 20(1A):345-9. PubMed ID: 10769678 [TBL] [Abstract][Full Text] [Related]
16. p53 protein expression in squamous cell carcinoma of the vulva. Scheistrøen M; Tropé C; Pettersen EO; Nesland JM Cancer; 1999 Mar; 85(5):1133-8. PubMed ID: 10091798 [TBL] [Abstract][Full Text] [Related]
17. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study. Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886 [TBL] [Abstract][Full Text] [Related]
18. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus. Takeuchi H; Ozawa S; Ando N; Shih CH; Koyanagi K; Ueda M; Kitajima M Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2229-36. PubMed ID: 9815619 [TBL] [Abstract][Full Text] [Related]
19. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection. Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120 [TBL] [Abstract][Full Text] [Related]
20. p53 protein expression in resected invasive esophageal cancer. Chyczewski L; Kozłowski M; Nikliński J; Szyszko J; Laudański J; Niklińska W Neoplasma; 1999; 46(3):150-5. PubMed ID: 10613589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]